Abstract
Selective infusion of urokinase into occluded coronary bypass vein grafts is effective in restoring patency. We report the occurrence of intracerebral hemorrhage complicating an intra-graft urokinase infusion protocol. The patient had known cerebral vascular structural pathology without recent clinical complications. Caution with the use of thrombolysis in this setting is suggested.
MeSH terms
-
Cerebral Hemorrhage / chemically induced*
-
Contraindications
-
Coronary Artery Bypass*
-
Graft Occlusion, Vascular / drug therapy*
-
Humans
-
Infusions, Intravenous
-
Male
-
Middle Aged
-
Saphenous Vein / transplantation
-
Thrombolytic Therapy / adverse effects*
-
Time Factors
-
Urokinase-Type Plasminogen Activator / administration & dosage
-
Urokinase-Type Plasminogen Activator / adverse effects*
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Urokinase-Type Plasminogen Activator